Masthead
 

Custom Search
ADVERTISEMENT
Today's Health Photos
GENEVA (Reuters) - The World Bank pledged $100 million on Thursday to help recruit more foreign health workers in the fight against Ebola, taking its funding for the three worst-hit countries to more than half a billion dollars over the past three months.

WASHINGTON (Reuters) - Saying she will not be bullied by politicians, a Maine nurse is giving the state an ultimatum: Lift her Ebola quarantine by Thursday or she will disregard the restrictions and go to court.

(Reuters Health) - After a year of emailing photos of their skin and communicating with their dermatologists online, eczema patients showed just as much improvement as people who saw their own doctors in person, according to a new study.

(Reuters) - A nurse in Maine vowing not to be bullied by politicians and threatening to sue the state over an Ebola quarantine she calls unscientifically sound, defied the order and left her home for a bike ride on Thursday, according to television images.

TOKYO (Reuters) - (This version corrects story to remove word "bio" in the fifth-last paragraph, and corrects disposible cameras to instant cameras in third last paragraph)

TEL AVIV (Reuters) - Teva Pharmaceutical Industries is optimistic the U.S. Supreme Court will decide in its favor regarding patent protection for Copaxone, its multiple sclerosis treatment, Chief Executive Erez Vigodman said on Thursday.

(Reuters) - Treatment of advanced squamous cell non-small cell lung cancer (NSCLC) with Bristol-Myers Squibb Co's experimental immunotherapy nivolumab led to a one-year survival rate of 41 percent in a midstage clinical trial, according to data being presented at a medical meeting.

MUMBAI (Reuters) - Generic drugmaker Cipla Ltd said on Thursday it has asked the Indian government to revoke five patents held by Swiss firm Novartis AG on respiratory drug Onbrez and has launched a cheaper copy to boost access in the local market.

HONG KONG (Reuters) - Chinese authorities have identified the southern province of Guangdong, home to Asia's biggest African population, as a frontline in their efforts to prevent the deadly Ebola virus from entering mainland China.

COPENHAGEN (Reuters) - Novo Nordisk is more cautious in its assessment of when it would launch its Tresiba diabetes drug in the United States, a critical growth driver for the future, according to statements it made in its quarterly report.

ADVERTISEMENT
Log into your Thames Valley Portal
Video
loading